Navigation Links
World AIDS Day Audio Press Conference
Date:11/26/2007

Thursday, November 29, 2007

10:00 a.m. (EST)

A World AIDS Day Call for Changes to PEPFAR's HIV Prevention Strategies

Leading U.S. and African Women's, Faith-based and Youth Rights Organizations Call on Congress to Start Taking Effective Prevention Seriously in Reauthorization of Global AIDS Plan

WASHINGTON, Nov. 26 /PRNewswire-USNewswire/ -- The following was released by the Center for Health & Gender Equity:

When: Thursday, November 29, 2007, at 10:00 a.m. EST

Who: Rev. William G. Sinkford, President, Unitarian Universalist

Association

Serra Sippel, Acting Executive Director, Center for Health

Gender Equity, moderator

Brian Ackerman, International Youth Leadership Council,

Advocates for Youth

Bernice Heloo, President, Society for Women and AIDS in Africa,

Ghana

Promise Mthembu, International Community of Women Living with

HIV and AIDS (ICW), invited

Rev. J.P. Heath, ANERELA, South Africa, invited

What: A World AIDS Day teleconference for international and national news media focusing on how U.S. international HIV prevention policy falls short of meeting the needs of women and youth, and on the steps Congress needs to take during the upcoming reauthorization of the President's Emergency Plan for AIDS Relief (PEPFAR) to address the prevention needs of women and youth.

The next day, on November 30, activists will participate in a march and rally in Washington, D.C. calling on Congress and the Administration to Start Taking Effective Prevention Seriously by taking the necessary steps to address the HIV prevention needs of women and youth worldwide. For more information on this event, visit http://www.pepfarwatch.org/index.php?option=com_content&task=view&id=106&It emid=106 or http://www.pepfarwatch.org/dcevent.

Why: World AIDS Day (December 1, 2007) marks the final World AIDS Day prior to the planned Congressional reauthorization of the President's Emergency Plan for AIDS Relief in 2008. It offers an opportunity to reflect on progress made under PEPFAR, as well as PEPFAR's shortcomings -- particularly the rising number of new HIV infections among women and youth. Current prevention policies under PEPFAR fail to address the needs of women and youth. As Congress prepares to reauthorize PEPFAR early in 2008, it is essential that they make critical reforms to PEPFAR's prevention programs.

RSVP: To join this call, RSVP to change@genderhealth.org, or call 1.301.270.1182, by 4:00 p.m. on November 28, 2007.

Co-sponsors: Advocates for Youth, Center for Health and Gender Equity, Unitarian Universalist Association of Congregations

http://www.pepfarwatch.org/press

Contact: Serra Sippel, CHANGE, 301-270-1182 (o), 301-768-7162 (m)

Marcela Howell, AFY, 202-419-3420 (o), 202-841-3292 (m)

Rob Keithan, UUA, 202-296-4672 x 15 (o), 202-494-6969 (m)


'/>"/>
SOURCE Center for Health & Gender Equity
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
(Date:1/19/2017)... CAMBRIDGE, England , January 19, 2017 ... MedImmune and Otsuka in the Milner Therapeutics Consortium   ... academic scientists in Cambridge   ... Inc. (NYSE: PFE ) as a partner ... join the Consortium, which enables the efficient transfer of ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... combining seaweeds, botanicals and 100 percent pure essential oils, announced the company had a ... Head, SC. , The annual ECRM event gives companies that work in the nutritional, ...
(Date:1/20/2017)... ... , ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality ... January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures ... its products to all clients at reasonable prices. At the ECRM trade show, it ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched two ... drinks have been produced in collaboration with Zlatan Ibrahimovic and have been developed ... After a successful launch in Sweden last year, the next generation sports drinks ...
Breaking Medicine News(10 mins):